Thymus-derived rosette-forming cells.

Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load. Clin Exp Immunol (1977) 1.25

T-cell depletion and in vitro thymosin inducibility in asthmatic children. Clin Exp Immunol (1978) 0.98

Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. J Clin Invest (1975) 0.97

Levamisole and human lymphocyte surface markers. Clin Exp Immunol (1977) 0.95

H-rosette formation in T-cell-proliferative diseases. Br Med J (1975) 0.94

Dynamics of T-lymphocyte subpopulations and T-lymphocyte function following thermal injury. Clin Exp Immunol (1978) 0.91

Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90

Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome. Clin Exp Immunol (1978) 0.90

Importance of methodology in demonstrating depression of T-lymphocyte levels. Br J Cancer (1978) 0.89

Increase of peripheral B lymphocytes in Graves' disease. Clin Exp Immunol (1980) 0.88

Letter: E-rosette inhibition test of T-lymphocyte sensitization. Br Med J (1974) 0.86

Human macromolecular insoluble cold globulin (MICG). I. T-cell origin of T-MICG and null cell origin of N-MICG. J Exp Med (1979) 0.81

On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis. J Neurol Neurosurg Psychiatry (1980) 0.81

Evidence for a T-cell reaction in the cutaneous sarcoid granuloma. Arch Dermatol Res (1977) 0.81

Active E rosette formation by human lymphoblasts. Immunology (1978) 0.80

In vivo and in vitro effects of doxycycline on leucocyte membrane receptors. Clin Exp Immunol (1985) 0.77

T and B lymphocytes in vitiligo. Arch Dermatol Res (1978) 0.75

Further similarities between Sézary syndrome and mycosis fungoides. Arch Dermatol Res (1978) 0.75

Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70

Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol (1967) 7.30

Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10

The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80

Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest (1973) 4.69

Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07

Isolation of normal T cells in chronic lymphatic leukaemia. Lancet (1973) 3.95

Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96

Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A (1970) 2.89

A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61

The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46

Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40

Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med (1966) 2.33

Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease. Science (1971) 2.27

Peyer's patches: morphologic studies. Cell Immunol (1970) 2.08

Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05

Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med (1973) 2.02

The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol (1974) 1.94

Immunohistological and elution studies of the human placenta. J Exp Med (1971) 1.88

A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83

The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82

The occurrence of antibodies to collagen in synovial fluids. Clin Immunol Immunopathol (1975) 1.74

"Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins. J Immunol (1969) 1.74

Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67

Rosette formation, a test for cellular immunity. Trans Assoc Am Physicians (1971) 1.64

Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62

Macroglobulinemia: an analysis for forty patients. Blood (1972) 1.61

The identity of light chains of monoclonal IgG and monoclonal IgM in one patient. Immunochemistry (1969) 1.58

Anionic sites on the membrane intercalated particles of human erythrocyte ghost membranes. Freeze-etch localization. Exp Cell Res (1973) 1.58

Impaired renal acidification in patients with hypergammaglobulinemia. Medicine (Baltimore) (1967) 1.55

Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55

Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation (1989) 1.50

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol (1989) 1.50

The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50

Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50

A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44

Selective absence of IgA: a family study. J Lab Clin Med (1968) 1.43

Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I. J Immunol (1980) 1.42

The nervous system and the pathophysiology of rheumatoid arthritis: the role of neurotensin and opioid peptides. J Rheumatol (1986) 1.40

Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39

Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor. J Immunol Methods (1977) 1.39

Leukocyte adherence inhibition test: cellular requirements for the elaboration of a polymorph adherence inhibition activity. Clin Immunol Immunopathol (1981) 1.39

Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39

Discussion paper: cross-reactivity of primate immunoglobulins. Ann N Y Acad Sci (1969) 1.38

Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production. J Exp Med (1972) 1.37

A new serum factor in normal rabbits. I. Identification and characterization. J Immunol (1965) 1.37

Genetically determined immune deficiency as the predisposing cause of "autoimmunity" and lymphoid neoplasia. Am J Med (1971) 1.36

Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein. J Exp Med (1970) 1.34

Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry (1970) 1.34

In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34

Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30

RElation of the human antibody response to flagellin to GM genotype. J Immunol (1971) 1.30

Effect of prednisolone on synthesis of DNA and RNA by human lymphocytes in vitro. Nature (1967) 1.29

Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nat New Biol (1973) 1.28

Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28

Immunologic deficiency, autoimmune disease, and lymphoma: observations, implications, and speculations. Arthritis Rheum (1966) 1.27

In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26

Peyer's patches: immunologic studies. J Exp Med (1970) 1.26

Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol (1979) 1.25

Inosiplex: a novel treatment in rheumatoid arthritis? J Rheumatol (1982) 1.25

Humoral immunity in vaginal candidiasis. Infect Immun (1977) 1.24

Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315. Proc Natl Acad Sci U S A (1973) 1.24

Quantitative studies of phytohemagglutinin-induced DNA and RNA synthesis in normal and agammaglobulinemic leukocytes. J Exp Med (1967) 1.23

On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry (1965) 1.23

Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinemia. Am J Med (1967) 1.22

Editorial: T-rosette forming cells, cellular immunity and cancer. N Engl J Med (1975) 1.22

Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement. J Immunol (1969) 1.21

Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20

Passive immune lysis with chromic chloride-treated erythrocytes. J Immunol (1969) 1.20

Further studies on the pathogenesis of rheumatoid joint inflammation. Arthritis Rheum (1966) 1.19

A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19

Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation. J Immunol (1975) 1.19

Disorders of neutrophil function. Defects in the early stages of the phagocytic process. Clin Exp Immunol (1973) 1.18

Unusual disease of pulmonary arteries with dyspnea. Structure-function relationships. Am J Med (1966) 1.18

The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications. J Immunol (1980) 1.17

Cellular immunity to platelets in idiopathic thrombocytopenic purpura. Blood (1972) 1.16

Transfer factor therapy in immune deficiency states. Annu Rev Med (1973) 1.16

The immune globulins. Annu Rev Microbiol (1965) 1.15

A genetic defect in "acquired" agammaglobulinemia. Proc Natl Acad Sci U S A (1968) 1.15

Rheumatoid factors and the etiology of rheumatoid arthritis. Ann N Y Acad Sci (1965) 1.13

Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets. Eur J Immunol (1985) 1.13

Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifugation. Blood (1980) 1.12

Thymosin: effects on normal human blood T-cells. Ann N Y Acad Sci (1975) 1.12

A selective neutrophil dysfunction syndrome: impaired killing of staphylococci. Ann Intern Med (1968) 1.12

Am(1), the first genetic marker of human immunoglobulin A. Proc Natl Acad Sci U S A (1969) 1.12

Defective RNA Synthesis in Lymphocytes from Patients with Primary Agammaglobulinemia. Science (1965) 1.12

Erythrocyte catabolism by macrophages in vitro. The effect of hydrocortisone on erythrophagocytosis and on the induction of heme oxygenase. J Clin Invest (1973) 1.12

A new subgroup of the Kappa chain variable region associated with anti-Pr cold agglutinins. Nat New Biol (1973) 1.11

The papain susceptibility of IgG myeloma proteins of different heavy chain subclasses. Immunochemistry (1970) 1.11

Cellular immune aspects of the human fetal-maternal relationship. I. In vitro response of cord blood lymphocytes to phytohemagglutinin. Cell Immunol (1972) 1.11

Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med (1970) 1.10